Chinese pharma firms fundraising to bolster R&D

Several Chinese firms are looking to raise money in order to bolster their research and development goals amid a volatile Chinese market. Established drug producers such as Jiangsu Hansoh and Simcere are said to be pondering Hong Kong IPOs later on this year.

Read the source article at ft.com